Meet Speedy, captain of Team Speedy. A new clip every morning.
See last night's clip →
Skip to main content
Hit enter to search or ESC to close
Close Search
search
Menu
About Us
MitoXcel™ Technology
Pipeline
Sarcopenia/Sarcopenic Obesity
Aging Research Hub
Team Speedy
Investors
Contact Us
search
Body Composition
GLP-1 On/Off Cycling
GLP-1s
Muscle
Obesity/Glucose Metabolic Disorders
Sarcopenia/Frailty
Sarcopenic Obesity
Uncategorized
Repeated Withdrawal of a GLPR Agonist Induces Hyperleptinemia and Deteriorates Metabolic Health in Obese Aging UM-HET3 Mice
By
kslawin
August 23, 2025
November 2nd, 2026
No Comments
Previous Post
MD Anderson and Phoenix SENOLYTIX announce cross-licensing agreement of CaspaCIDe™ for cell and gene therapies
Next Post
Metabolic Rewiring Caused by Mitochondrial Dysfunction Promotes mTORC1-Dependent Skeletal Aging
Leave a Reply
Cancel Reply
You must be
logged in
to post a comment.
Close Menu
About Us
MitoXcel™ Technology
Pipeline
Sarcopenia/Sarcopenic Obesity
Aging Research Hub
Team Speedy
Investors
Contact Us
